Schizophrenia: open trials in Croatia

• 2024-519836-18-00

  Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics

  Trial Treatment · Phase 3 · Newron Pharmaceuticals S.p.A.

  Clinic for psychiatry Sveti Ivan, Grad Zagreb

  Registry updated 2026-11-04

• NCT06540833

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  Trial Treatment · Phase 2 · Intra-Cellular Therapies, Inc.

  University Hospital Centre Zagreb, Zagreb · University Hospital Centre Zagreb 1, Zagreb · Psychiatric Clinic "VRAPCE", Zagreb · Polyclinic Neuron, Zagreb

  Registry updated 2026-11-03

• NCT06585787

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  Poliklinika Neuron, Grad Zagreb · Klinika za psihijatriju Vrapce, Grad Zagreb · Clinic for psychiatry Sveti Ivan, Grad Zagreb · University Hospital Centre Zagreb, Zagreb · Poliklinika Bonifarm, Zagreb

  Registry updated 2026-10-27

• NCT07288333

  Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

  Trial Treatment · Phase 2 · Neurocrine Biosciences

  Clinic for psychiatry Sveti Ivan, Grad Zagreb · Klinika za psihijatriju Vrapce, Grad Zagreb

  Registry updated 2026-07-22

• 2023-508981-13-00

  A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavailability at Steady-State of LY03010 versus XEPLION® in Patients with Schizophrenia

  Trial Treatment · Phase 1 · Geneora Pharma (Shijiazhuang) Co. Ltd.

  Klinika za psihijatriju Vrapce, Grad Zagreb · Clinic for psychiatry Sveti Ivan, Grad Zagreb · KBC Split, Split

  Registry updated 2024-08-27

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error